HARMONY BIOSCIENCES HLDGS IN's ticker is HRMY and the CUSIP is 413197104. A total of 60 filers reported holding HARMONY BIOSCIENCES HLDGS IN in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,618,163 | -40.7% | 201,958 | -36.3% | 0.00% | -50.0% |
| Q2 2023 | $11,155,336 | +4.1% | 317,003 | -3.5% | 0.00% | 0.0% |
| Q1 2023 | $10,720,105 | +78.5% | 328,334 | +201.2% | 0.00% | +100.0% |
| Q4 2022 | $6,007,222 | -18.1% | 109,024 | -34.2% | 0.00% | -50.0% |
| Q3 2022 | $7,335,000 | +120.3% | 165,611 | +142.6% | 0.00% | +100.0% |
| Q2 2022 | $3,330,000 | +7.5% | 68,277 | +7.3% | 0.00% | 0.0% |
| Q1 2022 | $3,097,000 | +54.8% | 63,659 | +35.7% | 0.00% | – |
| Q4 2021 | $2,000,000 | -4.3% | 46,906 | -14.0% | 0.00% | – |
| Q3 2021 | $2,090,000 | +159.3% | 54,516 | +90.9% | 0.00% | – |
| Q2 2021 | $806,000 | +76.4% | 28,561 | +106.7% | 0.00% | – |
| Q1 2021 | $457,000 | +42.4% | 13,820 | +55.5% | 0.00% | – |
| Q4 2020 | $321,000 | -75.1% | 8,885 | -76.7% | 0.00% | – |
| Q3 2020 | $1,290,000 | – | 38,063 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Valor Management LLC | 11,218,033 | $366,268,777 | 96.46% |
| venBio Partners LLC | 1,035,396 | $33,805,679 | 18.74% |
| Nan Fung Group Holdings Ltd | 368,665 | $12,036,912 | 8.19% |
| Vivo Capital, LLC | 2,606,247 | $85,093,965 | 5.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 570,500 | $18,621,120 | 5.20% |
| ASHFORD CAPITAL MANAGEMENT INC | 445,418 | $14,542,898 | 2.18% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 678,715 | $22,160,045 | 2.07% |
| TANG CAPITAL MANAGEMENT LLC | 321,200 | $10,487,180 | 1.56% |
| AlphaCentric Advisors LLC | 67,500 | $2,203,875 | 1.52% |
| Paradiem, LLC | 66,995 | $2,187,387 | 0.68% |